Package 33342-216-11

Brand: cevimeline hydrochloride

Generic: cevimeline hydrochloride
NDC Package

Package Facts

Identity

Package NDC 33342-216-11
Digits Only 3334221611
Product NDC 33342-216
Product ID 33342-216_67215459-3dd7-4538-9938-7d7315607fb6
Description

100 CAPSULE in 1 BOTTLE (33342-216-11)

Marketing

Marketing Status
Marketed Since 2024-10-20
Brand cevimeline hydrochloride
Generic cevimeline hydrochloride
Sample Package No

Linked Drug Pages (1)

Cevimeline Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "67215459-3dd7-4538-9938-7d7315607fb6", "openfda": {"unii": ["P81Q6V85NP"], "rxcui": ["309140"], "spl_set_id": ["990887c1-11ce-4a73-83b4-0ffc5a900c85"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (33342-216-11)", "package_ndc": "33342-216-11", "marketing_start_date": "20241020"}], "brand_name": "Cevimeline Hydrochloride", "product_id": "33342-216_67215459-3dd7-4538-9938-7d7315607fb6", "dosage_form": "CAPSULE", "pharm_class": ["Cholinergic Muscarinic Agonists [MoA]", "Cholinergic Receptor Agonist [EPC]"], "product_ndc": "33342-216", "generic_name": "Cevimeline Hydrochloride", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cevimeline Hydrochloride", "active_ingredients": [{"name": "CEVIMELINE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA206808", "marketing_category": "ANDA", "marketing_start_date": "20241020", "listing_expiration_date": "20271231"}